PD-2005

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePD-2005
Drug Alias NameDopamine transporter inhibitor (obesity/diabetes/TBI-induced cognitive impairments)PD-2005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine transporter antagonistsHistamine receptor antagonistsInsulin sensitizers
TargetsDopamine transporterHistamine receptor
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityCognition DisordersObesity +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesP2D Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesP2D Biosciences
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with HyperactivityCognition DisordersObesity +[4] 

Other Information

ATC CodeN/A
Related LinksN/A